# Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation

> **NCT03632564** · NA · UNKNOWN · sponsor: **Visior Technologies Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Cerebral Arterial Diseases

## Interventions

- **DEVICE:** REVIVIEW dichoptic audio-visual stimulation

## Key facts

- **NCT ID:** NCT03632564
- **Lead sponsor:** Visior Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-10
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-08-15
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03632564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03632564, "Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03632564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
